Mednet Logo
HomeQuestion

Do you avoid triptans in patients on SSRI's due to the potential risk of serotonin syndrome?

6
7 Answers
Mednet Member
Mednet Member
Neurology · Barrow Neurological Institute

I feel very comfortable using triptans with SSRIs/SNRIs.

In 2010, the American Headache Society released a position statement on this very issue:

Evans et al., PMID 20618823

Their position is that the available evidence does NOT support the claim that triptans should not be used with SSRIs or SNRIs.

A ...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Neurology · UCLA

Almost never. If someone was on huge doses of one or both drugs I might think about it. For about 25 years or more, I have gotten calls from pharmacies about prescribing the 2 together and I have said thank you, I will think more about it, but I do not believe there is a significant risk of serotoni...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Neurology · Greater Boston Headache Center at Boston Advanced Medicine

The short answer to this question is, NO. Triptans have very poor CNS penetration and are highly selective in their interaction with serotonin receptors. I am much more concerned about psychiatrists having patients on multiple medications that act on the serotonin system.

Register or Sign In to see full answer

Mednet Member
Mednet Member
Neurology · Quinnipiac Netter School of Medicine

I agree with the above and in 25 years of practice and seeing thousands of patients with headaches, I never saw serotonin syndrome.

Register or Sign In to see full answer

Mednet Member
Mednet Member
Neurology · University of Kentucky College of Medicine

There is a warning but I have never experienced serotonin syndrome as a side effect in any of my patients. Most of my adolescent patients are already on SSRIs.

Register or Sign In to see full answer

Mednet Member
Mednet Member
Psychiatry · Next Step 2 Mental Health

First things first, we’ve got to stop using the terminology ‘serotonin syndrome’. We’re talking about serotonin toxicity. My understanding is outside of the MAOI/SSRI (or SNrI) combination, serotonin toxicity is extremely rare. It requires blocking reuptake inhibition at two separate sites. Fatal to...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Neurology · UF Health

I agree with the comments, here is another recent article about the topic published by one of my colleagues:

Orlova et al., PMID 29482205

Register or Sign In to see full answer